| Dr Natalia Alexandrovna Piper, MD | |
|
10150 Centennial Pkwy, Ste. 230, Sandy, UT 84070-4103 | |
| (425) 284-1545 | |
| Not Available |
| Full Name | Dr Natalia Alexandrovna Piper |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 29 Years |
| Location | 10150 Centennial Pkwy, Sandy, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114964848 | NPI | - | NPPES |
| 8455073 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD00042884 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Community Hospital | Federal way, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Anesthesia Pc | 2961399290 | 75 |
News Archive
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).
An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Ambrx Inc. today announced the formation of a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance will capitalize on Ambrx's recent breakthroughs in applying its protein medicinal chemistry platform to proteins produced in mammalian cells such as antibodies and antibody-toxin conjugates.
Moderate to severely depressed clients showed greater improvement in cognitive therapy when therapists emphasized changing how they think rather than how they behave, new research has found.
› Verified 6 days ago
| Entity Name | Pacific Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497796452 PECOS PAC ID: 2961399290 Enrollment ID: O20040302000584 |
News Archive
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).
An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Ambrx Inc. today announced the formation of a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance will capitalize on Ambrx's recent breakthroughs in applying its protein medicinal chemistry platform to proteins produced in mammalian cells such as antibodies and antibody-toxin conjugates.
Moderate to severely depressed clients showed greater improvement in cognitive therapy when therapists emphasized changing how they think rather than how they behave, new research has found.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Natalia Alexandrovna Piper, MD Po Box 3630, Salt Lake City, UT 84110-3630 Ph: (866) 910-6157 | Dr Natalia Alexandrovna Piper, MD 10150 Centennial Pkwy, Ste. 230, Sandy, UT 84070-4103 Ph: (425) 284-1545 |
News Archive
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).
An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Ambrx Inc. today announced the formation of a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance will capitalize on Ambrx's recent breakthroughs in applying its protein medicinal chemistry platform to proteins produced in mammalian cells such as antibodies and antibody-toxin conjugates.
Moderate to severely depressed clients showed greater improvement in cognitive therapy when therapists emphasized changing how they think rather than how they behave, new research has found.
› Verified 6 days ago
Ralph Ernest Hannah, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9660 S 1300e, Sandy, UT 84094 Phone: 801-993-9582 Fax: 801-733-5618 | |
Mr. Clinton Lund Christensen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9660 South 1300 East, Alta View Hospital, Sandy, UT 84094 Phone: 801-501-2600 | |
Todd S Blood, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9660 South 1300 East, Alta View Hospital, Sandy, UT 84094 Phone: 801-501-2600 Fax: 801-733-5618 | |
James B Yee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9660 South 1300 East, Alta View Hospital, Sandy, UT 84094 Phone: 801-501-2600 Fax: 801-733-5618 | |
David A Pearson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 10011 S Centennial Pkwy, Suite 220, Sandy, UT 84070 Phone: 801-566-5350 Fax: 801-890-0706 | |
Jay Todd Nilson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10150 Centennial Pkwy Ste 230, Sandy, UT 84070 Phone: 800-594-5736 |